BenevolentAI (Euronext Amsterdam: BAI), a leading clinical-stage AI drug discovery company, today announces that it will participate in the following investor conferences:
- Goldman Sachs 43rd Annual Global Healthcare Conference in Rancho Palos Verdes, CA from June 13 – June 16, 2022
- Morgan Stanley, Putting the Tech in Biotech Conference, Exploring the World of Tech-Enabled Drug Development, in New York, NY on June 28, 2022
